Genmab A/S has shared new results from the Phase 1b/2 EPCORE® NHL-2 trial evaluating epcoritamab, a T-cell engaging bispecific antibody, in combination with lenalidomide and rituximab (R2) for treating relapsed…
A pooled analysis of the TROPION-Lung05 phase 2 and TROPION-Lung01 phase 3 trials demonstrated that datopotamab deruxtecan (Dato-DXd) achieved significant clinical responses in patients with previously treated advanced or metastatic…
MaaT Pharma, a clinical-stage biotechnology company specializing in Microbiome Ecosystem Therapies™ (MET) to improve cancer patient survival, announced the first treatment in the United States of a patient with acute…
VSee Health, Inc. (Nasdaq: VSEE), a leader in telehealth solutions known for its scalable technology and clinical expertise, has partnered with AbundaBox to launch AbundaLife™, an innovative health record management…
Exai Bio, a leading RNA- and AI-based liquid biopsy company, has announced the appointment of Karen E. Knudsen, MBA, PhD, to its board of directors. Knudsen, the former CEO of…
OnMed, a leading tech-enabled hybrid care company, is set to debut its innovative OnMed CareStation at CES 2025 in Las Vegas, Nevada. This breakthrough solution is transforming how underserved communities…
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive tests for early-stage cancer detection, will join Federal Supply System (FSS) officials today in a joint presentation. The…
Almirall, a global pharmaceutical company focused on medical dermatology, today unveiled “The Hive,” a groundbreaking scientific research hub located at its R&D center in Barcelona, Spain. The Hive is designed…
Henry Schein, Inc. (Nasdaq: HSIC) is showcasing a comprehensive range of dental solutions at the 2024 Greater New York Dental Meeting (GNYDM), taking place at the Henry Schein Dental (#4215)…
This giving season, we’re proud to highlight the incredible generosity of our employees who dedicate their time, talents, and financial resources to support and strengthen the communities where we live…
UnitedHealth Group (NYSE: UNH) has announced its financial guidance in advance of its annual Investor Conference, which will take place on December 4, starting at 8:00 a.m. ET. The company…
The American Red Cross’s Cell and Gene Therapy Solutions (CGTS) division, a leading provider of allogeneic cell therapy materials, has selected Accellix, Inc. to supply its automated flow cytometry platform…